Probably role of citicoline in stroke rehabilitation: Review of the literature;Posible papel de la citicolina en la rehabilitación tras un ictus: Revisión de la bibliografía

Revista de Neurologia

Volumn 54, Issue 3, 2012, Pages 173-179

  Secades, Julio J ^a  

^a Ferrer Grupo   (Spain)

Author keywords

Citicoline. neuroprotection. neurorepair. rehabilitation. sequelae. stroke. treatment

Indexed keywords

CITICOLINE;

DAILY LIFE ACTIVITY; DISABILITY; DISEASE SEVERITY; HUMAN; MORTALITY; NERVE CELL PLASTICITY; REHABILITATION CARE; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 84856786309     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5403.2011490     Document Type: Review

References (39)

1. World Health Organization: The World Health Report. Geneva: WHO; 1999.
2. Demaerschalk BM, Hwang HM, Leung G. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care 2010; 16: 525-33.
3. Dobkin BH. Rehabilitation after stroke. N Engl J Med 2005; 352: 1677-84.
4. Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36: e100-e43.
5. Carter AR, Connor LT, Dromerick AW. Rehabilitation after stroke: current state of the science. Curr Neurol Neurosci Rep 2010; 10: 158-66.
6. Cramer SC. Brain repair after stroke. N Engl J Med 2010; 362: 1827-9.
7. Díaz-Arribas MJ, Pardo-Hervás P, Tabares-Lavado M, Ríos-Lago M, Maestú F. Plasticidad del sistema nervioso central y estrategias de tratamiento para la reprogramación sensoriomotora: comparación de dos casos de accidente cerebrovascular isquémico en el territorio de la arteria cerebral media. Rev Neurol 2006; 42: 153-8.
8. Hurtado O, Pradillo JM, Alonso-Escolano D, Lorenzo P, Sobrino T, Castillo J, et al. Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis 2006; 21 (Suppl 2): S54-63.
9. Martínez-Vila E, Irimia P. Challenges of neuroprotection and neurorestoration in ischemic stroke treatment. Cerebrovasc Dis 2005; 20 (Suppl 2): S148-58.
10. Marsden D, Quinn R, Pond N, Golledge R, Neilson C, White J, et al. A multidisciplinary group programme in rural settings for community-dwelling chronic stroke survivors and their careers: a pilot randomized controlled trial. Clin Rehabil 2010; 24: 328-41.
11. Platz T, Eickhof C, Van Kaick S, Engel U, Pinkowski C, Kalok S, et al. Impairment-oriented training or Bobath therapy for severe arm paresis after stroke: a single-blind, multicentre randomized controlled trial. Clin Rehabil 2005; 19: 714-24.
12. Xue J, Bai L, Guo QR, Yang CR, Lu J. Efficacy of early intervention of motor relearning program on post-stroke hemiplegia: a randomized controlled observation. Neural Regeneration Research 2006; 1: 277-9.
13. Hoffmann T, Bennett S, Koh CL, McKenna K. A systematic review of cognitive interventions to improve functional ability in people who have cognitive impairment following stroke. Top Stroke Rehabil 2010; 17: 99-107.
14. Rekand T. Clinical assessment and management of spasticity: a review. Acta Neurol Scand Suppl 2010; 190: 62-6.
15. Beltran EJ, Papadopoulos CM, Tsai SY, Kartje GL, Wolf WA. Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole. Brain Res 2010; 1346: 174-82.
16. Santamato A, Panza F, Filoni S, Ranieri M, Solfrizzi V, Frisardi V, et al. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. Brain Inj 2010; 24: 1108-12.
17. Lokk J, Salman Roghani R, Delbari A. Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke -a randomized, double-blind, placebo-controlled trial. Acta Neurol Scand 2011; 123: 266-73.
18. Levy R, Ruland S, Weinand M, Lowry D, Dafer R, Bakay R. Cortical stimulation for the rehabilitation of patients with hemiparetic stroke: a multicenter feasibility study of safety and efficacy. J Neurosurg 2008; 108: 707-14.
19. Lim JY, Kang EK, Paik NJ. Repetitive transcranial magnetic stimulation to hemispatial neglect in patients after stroke: an open-label pilot study. J Rehabil Med 2010; 42: 447-52.
20. Kalra L, Ratan RR. Advances in stroke regenerative medicine 2007. Stroke 2008; 39: 273-5.
21. Döbrössy M, Busse M, Piroth T, Rosser A, Dunnett S, Nikkhah G. Neurorehabilitation with neural transplantation. Neurorehabil Neural Repair 2010; 24: 692-701.
22. Adibhatla RM, Hatcher JF. Role of lipids in brain injury and diseases. Future Lipidol 2007; 2: 403-22.
23. Saver JL. Target brain: neuroprotection and neurorestoration in ischemic stroke. Rev Neurol Dis 2010; 7 (Suppl 1): S14-21.
24. Secades JJ. Citicolina: revisión farmacológica y clínica, actualización 2010. Rev Neurol 2011; 52 (Supl 2): S1-62.
25. Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis 2007; 26: 105-11.
26. Carnevale D, De Simone R, Minghetti L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol Disord Drug Targets 2007; 6: 388-97.
27. Bramanti V, Campisi A, Tomassoni D, Li Volti G, Caccamo D, Cannavò G, et al. Effect of acetylcholine precursors on proliferation and differentiation of astroglial cells in primary cultures. Neurochem Res 2008; 33: 2601-8.
28. Lee HJ, Kang JS, Kim YI. Citicoline protects against cognitive impairment in a rat model of chronic cerebral hypoperfusion. J Clin Neurol 2009; 5: 33-8.
29. Gutiérrez M, Rodríguez B, Álvarez J, Expósito M, Vallejo M, Merino J, et al. Effects of citicoline and mesenchymal stem cells in acute cerebral infarct. Experimental study in rats. Cerebrovasc Dis 2010; 29 (Suppl 2): S1-341.
30. Dávalos A, Castillo J, Álvarez-Sabín J, Secades JJ, Mercadal J, López S, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002; 33: 2850-7.
31. Saver JL. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis 2008; 5: 167-77.
32. Casado A, Secades JJ, Ibarz R, Herdman M, Brosa M. Cost-effectiveness of citicoline versus conventional treatment in acute ischemic stroke. Expert Rev Pharmacoecon Outcomes Res 2008; 8: 151-7.
33. Cho HJ, Kim YJ. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases. Methods Find Exp Clin Pharmacol 2009; 31: 171-6.
34. Sobrino T, Rodríguez-González R, Blanco M, Brea D, PérezMato M, Rodríguez-Yáñez M, et al. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res 2011; 33: 572-7.
35. Fioravanti M, Yanagi M. Cytidinediphosphocholine for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005; 2: CD000269.
36. Álvarez-Sabín J, Román G. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 2011; 42 (Suppl 1): S40-3.
37. Hazama T, Hasegawa T, Ueda S, Sakuma A. Evaluation of the effect of CDP-choline on post-stroke hemiplegia employing a double-blind controlled trial. Int J Neurosci 1980; 11: 211-25.
38. Ueda S, Hasegawa T, Ando K, Okawa T, Chino N, Ogata H, et al. Evaluation of the pharmacological effect of CDP-choline injection in post-stroke hemiplegia. Double-blind comparative study using the Hemiplegia Function Test (12-grade evaluation method). Strides of Medicine 1994; 170: 297-314.
39. Iranmanesh F, Vakilian A. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial. J Stroke Cerebrovasc Dis 2008; 17: 153-5.